New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2005 to 2023. Read More.
Open Access Percentage
77%
Total
Publications
114
Total Open
Publications
88
Total
Citations
3.1K
Open Access
Percentage
77%
Total
Publications
114
Total Open
Publications
88
Total
Citations
3.1K
Breakdown
Publisher Open
8%
Both
53%
Other Platform Open
16%
Closed
23%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 43%
30
Hybrid 40%
28
No Guarantees 17%
12
Other Platform Open
Domain 57%
45
Preprint 37%
29
Other Internet 23%
18
Institution 15%
12
Public 9%
7
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 43 |
Europe PMC | Domain | 25 |
bioRxiv | Preprint | 17 |
Research Square | Preprint | 14 |
Unknown Repository | Other Internet | 9 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 6 |
Semantic Scholar | Public | 5 |
DOI | Other Internet | 4 |
University of Sussex - Sussex Research Online | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 3 |